Andrew,
*****News release********
biz.yahoo.com
Friday May 1, 9:10 am Eastern Time
Company Press Release
SOURCE: SafeScience, Inc.
MIGAL Will Be The First SafeScience Institute
SafeScience, Inc. Enters Into Research Partnership With MIGAL Galilee Technology Center
BOSTON, May 1 /PRNewswire/ -- SafeScience, Inc., (OTC Bulletin Board: SAFS - news) today announced the signing of a definitive agreement with MIGAL Galilee Technology Center (MIGAL) in Kiryat Shmona, Israel whereby MIGAL will act as a partner in developing new products that will be commercialized under the world brand, SafeScience(R).
''We welcome the opportunity to collaborate with SafeScience, Inc., and become part of the growing number of SafeScience(R) affiliated companies around the world,'' stated Jacob Arzi, General Manager of MIGAL Galilee Technology Center. ''MIGAL will make a considerable contribution to the brand SafeScience(R) because of our resources and technology to creating products that are based on natural sources.''
''MIGAL's adoption of the name SafeScience(R) represents the true spirit of our partnership and is the first step towards building a family of SafeScience institutes around the world,'' stated Bradley Carver, President of SafeScience, Inc. ''The concept of establishing a SafeScience institute is an important component in our exciting model and effort to build the SafeScience(R) world brand.''
MIGAL is a highly respected scientific institute established in 1979. It is dedicated to research and development in the area of agricultural and environmental biotechnology, including plant, pathogens and human genetics. R&D activities include development of improved crops, virology, recombinant vaccine for human and animals, immunology, molecular biology. Other applied research activities include aquaculture for nutrition and control of reproduction, production of fungal enzymes, biodegradation of toxic compounds, soil and water microbiology for bioremediation of pollution, composting urban and agricultural wastes and anaerobic digestion of animal and industrial wastes. MIGAL employs over 100 researchers, engineers, and graduate students for higher degrees including Ph.D. degree and technicians.
Details of the agreement include the co-development of certain projects currently underway at MIGAL and also to develop new products and technologies for SafeScience(R). This agreement allows MIGAL to identify itself as a SafeScience(R) Institute and give SafeScience(R) the option to purchase an equity stake in MIGAL.
SafeScience, Inc. (formerly IGG International, Inc.) is developing and marketing a portfolio of efficacious agricultural and pharmaceutical products under the brand 'SafeScience(R)' as an alternative to conventional treatments employing potentially harmful chemicals. Beyond the Company's agricultural products, its human therapeutic products include a carbohydrate compound to treat cancer, which is in human clinical trials, as well as an antifungal compound. Further information is available on SafeScience's web site: safesci.com.
Any statements contained in this release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including, but not limited to, risks of product nonapproval or product development and market acceptance risks, the impact of competitive products and pricing, the results of current and future licensing and other collaborative relationships, the results of financing efforts, developments regarding intellectual property rights and litigation, and other risks identified in the Company's Securities and Exchange Commission filings. Actual results, events or performance may differ materially. Readers are cautioned not to place undo reliance on these forward-looking statements, which speak only as the date hereof. The Company undertakes no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
SOURCE: SafeScience, Inc.
--------------------------------------------------------------------------------
More Quotes and News: SafeScience Inc (OTC BB:SAFS - news)
Related News Categories: medical/pharmaceutical
Smile
Redhead |
